Inflammatory disorders associated with trisomy 8‐myelodysplastic syndromes: French retrospective case‐control study

We report cases of myelodysplastic syndrome/myeloproliferative neoplasms (MDS/MPN) with trisomy 8 associated with inflammatory and autoimmune diseases (IADs).

[1]  R. Moots,et al.  2018 update of the EULAR recommendations for the management of Behçet’s syndrome , 2018, Annals of the rheumatic diseases.

[2]  O. Decaux,et al.  Efficacy of Azacitidine in Autoimmune and Inflammatory Disorders associated with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Running title : Azacitidine in autoimmune disorders associated with MDS / CMML , 2018 .

[3]  E. Lee,et al.  Certain Autoimmune Manifestations Are Associated With Distinctive Karyotypes and Outcomes in Patients With Myelodysplastic Syndrome , 2016, Medicine.

[4]  J. Piette,et al.  Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. , 2016, Rheumatology.

[5]  I. Olivieri,et al.  The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria , 2014 .

[6]  Queiroz,et al.  The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[7]  D. Henrion,et al.  Systemic and immune manifestations in myelodysplasia: A multicenter retrospective study , 2011, Arthritis care & research.

[8]  P. Nguyen,et al.  Myelodysplastic syndromes , 2009, Nature Reviews Disease Primers.

[9]  Toong-Hua Liang,et al.  Behçet disease associated with myelodysplastic syndrome. , 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[10]  Y. Tada,et al.  The association of Behçet's disease with myelodysplastic syndrome in Japan: a review of the literature. , 2006, Clinical and experimental rheumatology.

[11]  B. Cheson,et al.  Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. , 2006, Blood.

[12]  S. Giannouli,et al.  Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. , 2004, Rheumatology.

[13]  Jie Jin,et al.  [Clinical and experimental study of 38 cases with trisomy 8]. , 2003, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[14]  A. Duhamel,et al.  Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. , 1993, Leukemia.